4 completed, 3 terminated. 7 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 4, Terminated 3 |
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow Acetylcholine: new trials by email Literature Review of Acetylcholine trials Research Report on Acetylcholine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HeartPhone Cancer Survivors Trial 2019 HeartPhone app, Acetylcholine, Sodium Nitroprusside - Breast Cancer, Leukemia | Phase 1 / Phase 2 | Terminated | Penn State University | 2 | 2019-04-23 | 2026-02-27 |
| Anemia Study in Chronic Kidney Disease (CKD) : Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat -Forearm Blood Flow (ASCEND-FBF) Daprodustat, Darbepoetin alfa, Acetylcholine - Anaemia | Phase 2 | Terminated | GlaxoSmithKline | 6 | 2019-01-10 | 2024-03-27 |
| Niacin to Improve Blood Flow in People With Sickle Cell Disease Niacin-ER, Placebo, L-NMMA - Sickle Cell Disease | Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 30 | 2007-07-24 | 2020-09-10 |
| Model System for Transient Forearm Blood Vessel Dysfunction Limb Ischemia, Acetylcholine - Limb Ischemia, Ischemic Preconditioning | Phase 1 / Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 6 | 2007-03-26 | 2022-08-09 |
| Endothelial Hyperpolarization in Humans Tetraethylammonium (TEA), L-NG-monomethyl Arginine (L-NMMA), Bradykinin - Hyperlipidemia | Phase 2 | Terminated | Emory University | 174 | 2002-07-01 | 2018-08-15 |
| Nitric Oxide to Improve Blood Flow in Sickle Cell Disease L-NMMA, Acetylcholine - Sickle Cell Anemia | Phase 2 | Completed | National Institutes of Health Clinical Center (CC) | 65 | 2001-01-01 | 2008-03-04 |
| Study of the Effects of Vitamin C on Patients With Type 2 Diabetes Acetylcholine - Diabetes Mellitus, Non-Insulin Dependent, Non-Insulin Dependent | Phase 2 | Completed | National Center for Complementary and Integrative Health (NCCIH) | 150 | 1999-01-01 | 2008-03-04 |
Anemia, Sickle Cell (2) · Anemia (1) · Ascorbic Acid Deficiency (1) · Breast Neoplasms (1) · Diabetes Mellitus, Type 2 (1) · Hyperlipidemias (1) · Insulin Resistance (1) · Leukemia (1) · Lymphoma (1)
National Heart, Lung, and Blood Institute (NHLBI) (2) · Emory University (1) · GlaxoSmithKline (1) · National Center for Complementary and Integrative Health (NCCIH) (1) · National Institutes of Health Clinical Center (CC) (1) · Penn State University (1)
United States (6) · United Kingdom (1)
Arshed A Quyyumi, MD (1) · John F Tisdale, M.D. (1)
PMID 21555712, PMID 24675657, PMID 24925526, PMID 25648989, PMID 36005278
2017 (1), R01HL079115 (1)